Ascelia Pharma Announces Publication of Orviglance Study in Investigative Radiology
Ascelia Pharma (STO:ACE) - Ascelia Pharma AB (publ) (ticker:ACE), a biotech focused on improving the life of people living with rare cancer conditions, today announced the publication of a scientific article in the journal Investigative Radiology. The article features its orphan drug candidate Orviglance® in a comparison study to unenhanced MRI and to gadolinium.The publication titled ‘Lesion Visualization of an Oral Manganese Contrast Agent...
Read more








